Drug Profile
Research programme: MIF inhibitors - Ferring Pharmaceuticals
Alternative Names: CPSI-1306; CPSI-2705; Macrophage Migration Inhibitory Factor inhibitors - Ferring PharmaceuticalsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cytokine PharmaSciences
- Class Small molecules
- Mechanism of Action Macrophage migration inhibitory factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Arthritis; Cancer; Diabetes mellitus; Glomerulonephritis; Multiple sclerosis; Septic shock; Ulcerative colitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Arthritis in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA (PO)